Featured Research

from universities, journals, and other organizations

Stopping "Cellular Suicide" Could Boost Production In Biotech Labs

Date:
July 22, 1997
Source:
Johns Hopkins University
Summary:
Stopping human cells from committing suicide when their environment changes is crucial to the biotechnology industry, which uses such cells to manufacture pharmaceuticals. A team of engineers and scientists at Johns Hopkins is working to disable the weapons the cells use to kill themselves.

THE JOHNS HOPKINS UNIVERSITYOFFICE OF NEWS AND INFORMATION

3400 N. Charles StreetBaltimore, Maryland 21218-2692Phone: (410) 516-7160 / Fax (410) 516-5251

----------------------------------------------------------------

July 15, 1997FOR IMMEDIATE RELEASECONTACT: Phil Sneidermanprs@jhu.edu

STOPPING "CELLULAR SUICIDE" COULD BOOST PRODUCTION IN BIOTECH LABS

Every day, for reasons that are not clearly understood, somehuman cells commit suicide. Some cells, such as those that havebeen infected by a virus, kill themselves to preserve the healthof the body as a whole. Other self-destruct simply because theysense that a threat to their survival or merely somethingunfamiliar is lurking nearby.

This process, called apoptosis or programmed cell death, is anormal biological occurrence that can promote proper organdevelopment and help to prevent cancer. But it's unwelcome inmodern biotech labs, where scientists turn living cells intominiature pharmaceutical factories that produce proteins,enzymes, antibodies and viruses to help patients with an array ofillnesses. Apoptosis prompts many of these microscopic workers toput physiological "guns to their heads" after just a few days onthe job. Working closely with molecular biologists, Johns HopkinsUniversity engineer Michael J. Betenbaugh is trying to disablethese guns and allow the drug-making cells to lead longer, moreproductive lives.

"Ideally, we'd like to extend the lifetime of these cells andincrease their efficiency in making biotech products that savepeople's lives," says Betenbaugh, an associate professor in theDepartment of Chemical Engineering.

His research has important implications. If scientists find a wayto stop cellular suicide, they may be able to keep some cardiaccells from killing themselves after a heart attack. They may alsobe able to extend the life of artificial organs made from animaltissue.

The key is to halt apoptosis, which is often triggered by changesin a cell's environment. "It may be a viral infection, the lossof a key nutrient, radiation or a chemical toxin, all at sub-lethal levels," Betenbaugh explains. "These would not kill thecell by themselves. Nevertheless, the cell turns on thisphysiological chain of events that causes it to self-destruct."

In biotech labs, however, researchers want genetically engineeredcells to thrive and produce medicines for as long as possible, agoal that is thwarted by programmed cell death. To remove thisstumbling block, Betenbaugh installs "stop signals" at specificpoints along a cell's road toward self-destruction. To find thesesignals, he works with researchers led by J. Marie Hardwick, anassociate professor of molecular microbiology and immunology atThe Johns Hopkins School of Public Health. Hardwick's team ismapping out the genetic path that a cell follows toward self-destruction. In his own biotech lab, Betenbaugh uses thesefindings to figure out the best way to block the cell's progressalong this path.

"There is a point of no return as the cell goes through theprocess of killing itself," Betenbaugh explains. "But at somepoint you can stop it. I'm collaborating with the biologists whoare figuring out what those stop signals are. Then, as anengineer, my job is to apply those stop signals to the cell linesthat I'm developing."

One potential stop signal is membrane protein called bcl-2. Whenthis material is inserted during the genetic engineering of a newcell line, it appears to shut down the suicidal impulses,Betenbaugh says. He is also experimenting with chemicals thatmimic the effects of bcl-2 when added to cells that are alreadygrowing in the lab. "Maybe our cells see the signals that tellthem to commit suicide," Betenbaugh says. "But we can halt thatprocess before it hits the point of no return. Instead of dyingafter two days, our cells might live for six or seven days,making pharmaceuticals for a longer period of time."

In his initial experiments, Betenbaugh has more than doubled thelife-span of some biotech lab cells. Thus far, however, each ofthese hardier cells has not produced as much medicine as the onesthat died quickly. By trying new genetic and chemical strategies,the researcher seeks to improve the system significantly in thenear future. "We want to find the combination that will allowthese cells to work more efficiently and live longer," Betenbaughsays. "That's what this research is all about."

###


Story Source:

The above story is based on materials provided by Johns Hopkins University. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins University. "Stopping "Cellular Suicide" Could Boost Production In Biotech Labs." ScienceDaily. ScienceDaily, 22 July 1997. <www.sciencedaily.com/releases/1997/07/970722090258.htm>.
Johns Hopkins University. (1997, July 22). Stopping "Cellular Suicide" Could Boost Production In Biotech Labs. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/1997/07/970722090258.htm
Johns Hopkins University. "Stopping "Cellular Suicide" Could Boost Production In Biotech Labs." ScienceDaily. www.sciencedaily.com/releases/1997/07/970722090258.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins